nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—breast cancer	0.212	0.642	CbGaD
Trimethoprim—TYMS—Capecitabine—breast cancer	0.0748	0.165	CbGbCtD
Trimethoprim—CYP3A4—breast cancer	0.0647	0.195	CbGaD
Trimethoprim—ABCB1—breast cancer	0.0538	0.163	CbGaD
Trimethoprim—TYMS—Gemcitabine—breast cancer	0.0519	0.114	CbGbCtD
Trimethoprim—TYMS—Fluorouracil—breast cancer	0.0444	0.0977	CbGbCtD
Trimethoprim—DHFR—Methotrexate—breast cancer	0.0351	0.0773	CbGbCtD
Trimethoprim—TYMS—Methotrexate—breast cancer	0.0245	0.0539	CbGbCtD
Trimethoprim—CYP2C9—Anastrozole—breast cancer	0.0143	0.0314	CbGbCtD
Trimethoprim—CYP2C8—Lapatinib—breast cancer	0.0136	0.0301	CbGbCtD
Trimethoprim—ABCB1—Toremifene—breast cancer	0.0127	0.0279	CbGbCtD
Trimethoprim—CYP3A4—Exemestane—breast cancer	0.0109	0.0241	CbGbCtD
Trimethoprim—CYP2C9—Idarubicin—breast cancer	0.0108	0.0238	CbGbCtD
Trimethoprim—CYP2C8—Raloxifene—breast cancer	0.0103	0.0228	CbGbCtD
Trimethoprim—CYP3A4—Letrozole—breast cancer	0.00931	0.0205	CbGbCtD
Trimethoprim—ABCB1—Lapatinib—breast cancer	0.00924	0.0203	CbGbCtD
Trimethoprim—CYP3A4—Anastrozole—breast cancer	0.0083	0.0183	CbGbCtD
Trimethoprim—CYP3A4—Toremifene—breast cancer	0.00759	0.0167	CbGbCtD
Trimethoprim—CYP3A4—Fulvestrant—breast cancer	0.00705	0.0155	CbGbCtD
Trimethoprim—CYP2C8—Tamoxifen—breast cancer	0.00683	0.015	CbGbCtD
Trimethoprim—CYP3A4—Thiotepa—breast cancer	0.00629	0.0138	CbGbCtD
Trimethoprim—CYP2C9—Capecitabine—breast cancer	0.00592	0.013	CbGbCtD
Trimethoprim—CYP3A4—Ixabepilone—breast cancer	0.00575	0.0127	CbGbCtD
Trimethoprim—CYP3A4—Lapatinib—breast cancer	0.00553	0.0122	CbGbCtD
Trimethoprim—CYP2C8—Paclitaxel—breast cancer	0.00532	0.0117	CbGbCtD
Trimethoprim—ABCB1—Vinorelbine—breast cancer	0.00512	0.0113	CbGbCtD
Trimethoprim—CYP2C8—Fluorouracil—breast cancer	0.00504	0.0111	CbGbCtD
Trimethoprim—CYP2C9—Tamoxifen—breast cancer	0.00477	0.0105	CbGbCtD
Trimethoprim—ABCB1—Tamoxifen—breast cancer	0.00463	0.0102	CbGbCtD
Trimethoprim—ABCB1—Mitoxantrone—breast cancer	0.00451	0.00993	CbGbCtD
Trimethoprim—CYP3A4—Raloxifene—breast cancer	0.00419	0.00924	CbGbCtD
Trimethoprim—ABCB1—Gemcitabine—breast cancer	0.00398	0.00877	CbGbCtD
Trimethoprim—CYP2C9—Paclitaxel—breast cancer	0.00371	0.00817	CbGbCtD
Trimethoprim—ABCB1—Paclitaxel—breast cancer	0.0036	0.00793	CbGbCtD
Trimethoprim—ABCB1—Irinotecan—breast cancer	0.00355	0.00782	CbGbCtD
Trimethoprim—CYP2C9—Fluorouracil—breast cancer	0.00351	0.00773	CbGbCtD
Trimethoprim—ABCB1—Vinblastine—breast cancer	0.00316	0.00695	CbGbCtD
Trimethoprim—CYP3A4—Vinorelbine—breast cancer	0.00307	0.00676	CbGbCtD
Trimethoprim—CYP3A4—Tamoxifen—breast cancer	0.00277	0.0061	CbGbCtD
Trimethoprim—CYP3A4—Mitoxantrone—breast cancer	0.0027	0.00595	CbGbCtD
Trimethoprim—ABCB1—Docetaxel—breast cancer	0.0026	0.00573	CbGbCtD
Trimethoprim—CYP3A4—Paclitaxel—breast cancer	0.00216	0.00475	CbGbCtD
Trimethoprim—CYP3A4—Irinotecan—breast cancer	0.00213	0.00469	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—breast cancer	0.00194	0.00427	CbGbCtD
Trimethoprim—CYP3A4—Vinblastine—breast cancer	0.00189	0.00417	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—breast cancer	0.00188	0.00414	CbGbCtD
Trimethoprim—CYP3A4—Docetaxel—breast cancer	0.00156	0.00343	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—breast cancer	0.00116	0.00256	CbGbCtD
Trimethoprim—DHFR—nipple—breast cancer	0.00112	0.0642	CbGeAlD
Trimethoprim—DHFR—embryo—breast cancer	0.000922	0.053	CbGeAlD
Trimethoprim—TYMS—skin of body—breast cancer	0.000723	0.0415	CbGeAlD
Trimethoprim—TYMS—endometrium—breast cancer	0.000682	0.0392	CbGeAlD
Trimethoprim—DHFR—endometrium—breast cancer	0.000675	0.0388	CbGeAlD
Trimethoprim—CYP2C8—mammary gland—breast cancer	0.000671	0.0386	CbGeAlD
Trimethoprim—DHFR—uterus—breast cancer	0.000622	0.0357	CbGeAlD
Trimethoprim—TYMS—adipose tissue—breast cancer	0.000614	0.0353	CbGeAlD
Trimethoprim—DHFR—pituitary gland—breast cancer	0.000611	0.0351	CbGeAlD
Trimethoprim—DHFR—adipose tissue—breast cancer	0.000608	0.035	CbGeAlD
Trimethoprim—CYP2C9—mammary gland—breast cancer	0.000596	0.0342	CbGeAlD
Trimethoprim—TYMS—female reproductive system—breast cancer	0.000565	0.0324	CbGeAlD
Trimethoprim—DHFR—female reproductive system—breast cancer	0.000559	0.0321	CbGeAlD
Trimethoprim—TYMS—Docetaxel—Paclitaxel—breast cancer	0.000552	0.226	CbGdCrCtD
Trimethoprim—TYMS—adrenal gland—breast cancer	0.000551	0.0317	CbGeAlD
Trimethoprim—DHFR—adrenal gland—breast cancer	0.000545	0.0314	CbGeAlD
Trimethoprim—TYMS—Gefitinib—Lapatinib—breast cancer	0.000541	0.221	CbGdCrCtD
Trimethoprim—TYMS—bone marrow—breast cancer	0.000533	0.0306	CbGeAlD
Trimethoprim—DHFR—bone marrow—breast cancer	0.000528	0.0303	CbGeAlD
Trimethoprim—TYMS—female gonad—breast cancer	0.000514	0.0295	CbGeAlD
Trimethoprim—DHFR—female gonad—breast cancer	0.000509	0.0292	CbGeAlD
Trimethoprim—TYMS—endocrine gland—breast cancer	0.000478	0.0275	CbGeAlD
Trimethoprim—DHFR—endocrine gland—breast cancer	0.000473	0.0272	CbGeAlD
Trimethoprim—CYP2C8—endometrium—breast cancer	0.000335	0.0193	CbGeAlD
Trimethoprim—TYMS—lymph node—breast cancer	0.00033	0.019	CbGeAlD
Trimethoprim—DHFR—lymph node—breast cancer	0.000327	0.0188	CbGeAlD
Trimethoprim—CYP2C8—pituitary gland—breast cancer	0.000303	0.0174	CbGeAlD
Trimethoprim—CYP2C8—female reproductive system—breast cancer	0.000278	0.0159	CbGeAlD
Trimethoprim—TYMS—Paclitaxel—Docetaxel—breast cancer	0.000276	0.113	CbGdCrCtD
Trimethoprim—CYP2C9—female reproductive system—breast cancer	0.000246	0.0142	CbGeAlD
Trimethoprim—CYP2C8—endocrine gland—breast cancer	0.000235	0.0135	CbGeAlD
Trimethoprim—ABCB1—embryo—breast cancer	0.000219	0.0126	CbGeAlD
Trimethoprim—CYP2C9—endocrine gland—breast cancer	0.000209	0.012	CbGeAlD
Trimethoprim—TYMS—Vincristine—Vinorelbine—breast cancer	0.000189	0.0775	CbGdCrCtD
Trimethoprim—CYP3A4—female reproductive system—breast cancer	0.000188	0.0108	CbGeAlD
Trimethoprim—ABCB1—epithelium—breast cancer	0.000179	0.0103	CbGeAlD
Trimethoprim—TYMS—Vinorelbine—Vinblastine—breast cancer	0.000177	0.0725	CbGdCrCtD
Trimethoprim—ABCB1—endometrium—breast cancer	0.000161	0.00923	CbGeAlD
Trimethoprim—CYP3A4—endocrine gland—breast cancer	0.000159	0.00914	CbGeAlD
Trimethoprim—TYMS—Vinblastine—Vinorelbine—breast cancer	0.000152	0.0623	CbGdCrCtD
Trimethoprim—TYMS—Vincristine—Vinblastine—breast cancer	0.000151	0.062	CbGdCrCtD
Trimethoprim—ABCB1—uterus—breast cancer	0.000148	0.00851	CbGeAlD
Trimethoprim—ABCB1—pituitary gland—breast cancer	0.000145	0.00835	CbGeAlD
Trimethoprim—ABCB1—adipose tissue—breast cancer	0.000145	0.00832	CbGeAlD
Trimethoprim—ABCB1—female reproductive system—breast cancer	0.000133	0.00765	CbGeAlD
Trimethoprim—ABCB1—adrenal gland—breast cancer	0.00013	0.00746	CbGeAlD
Trimethoprim—ABCB1—bone marrow—breast cancer	0.000126	0.00722	CbGeAlD
Trimethoprim—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	0.000122	0.0499	CbGdCrCtD
Trimethoprim—ABCB1—female gonad—breast cancer	0.000121	0.00696	CbGeAlD
Trimethoprim—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	0.000119	0.0487	CbGdCrCtD
Trimethoprim—ABCB1—endocrine gland—breast cancer	0.000113	0.00647	CbGeAlD
Trimethoprim—TYMS—Danazol—Fluoxymesterone—breast cancer	9.22e-05	0.0377	CbGdCrCtD
Trimethoprim—ABCB1—lymph node—breast cancer	7.78e-05	0.00447	CbGeAlD
Trimethoprim—TYMS—Azacitidine—Gemcitabine—breast cancer	7.13e-05	0.0292	CbGdCrCtD
Trimethoprim—Epistaxis—Epirubicin—breast cancer	4.16e-05	0.000353	CcSEcCtD
Trimethoprim—Pruritus—Gemcitabine—breast cancer	4.16e-05	0.000353	CcSEcCtD
Trimethoprim—Nausea—Thiotepa—breast cancer	4.15e-05	0.000352	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—breast cancer	4.15e-05	0.000352	CcSEcCtD
Trimethoprim—Diarrhoea—Mitoxantrone—breast cancer	4.13e-05	0.00035	CcSEcCtD
Trimethoprim—Diarrhoea—Irinotecan—breast cancer	4.13e-05	0.00035	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—breast cancer	4.12e-05	0.000349	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—breast cancer	4.11e-05	0.000348	CcSEcCtD
Trimethoprim—Shock—Docetaxel—breast cancer	4.11e-05	0.000348	CcSEcCtD
Trimethoprim—Nervous system disorder—Docetaxel—breast cancer	4.09e-05	0.000347	CcSEcCtD
Trimethoprim—Pruritus—Fluorouracil—breast cancer	4.09e-05	0.000347	CcSEcCtD
Trimethoprim—Thrombocytopenia—Docetaxel—breast cancer	4.09e-05	0.000347	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—breast cancer	4.09e-05	0.000346	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—breast cancer	4.09e-05	0.000346	CcSEcCtD
Trimethoprim—Confusional state—Capecitabine—breast cancer	4.08e-05	0.000346	CcSEcCtD
Trimethoprim—Feeling abnormal—Paclitaxel—breast cancer	4.06e-05	0.000344	CcSEcCtD
Trimethoprim—Skin disorder—Docetaxel—breast cancer	4.06e-05	0.000344	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—breast cancer	4.05e-05	0.000343	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Paclitaxel—breast cancer	4.03e-05	0.000341	CcSEcCtD
Trimethoprim—Diarrhoea—Gemcitabine—breast cancer	4.03e-05	0.000341	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—breast cancer	4.02e-05	0.00034	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—breast cancer	4e-05	0.000339	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—breast cancer	4e-05	0.000339	CcSEcCtD
Trimethoprim—Dizziness—Irinotecan—breast cancer	3.99e-05	0.000339	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—breast cancer	3.98e-05	0.000338	CcSEcCtD
Trimethoprim—Anorexia—Docetaxel—breast cancer	3.98e-05	0.000337	CcSEcCtD
Trimethoprim—Shock—Capecitabine—breast cancer	3.98e-05	0.000337	CcSEcCtD
Trimethoprim—Nervous system disorder—Capecitabine—breast cancer	3.96e-05	0.000336	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—breast cancer	3.96e-05	0.000336	CcSEcCtD
Trimethoprim—Diarrhoea—Fluorouracil—breast cancer	3.96e-05	0.000336	CcSEcCtD
Trimethoprim—Thrombocytopenia—Capecitabine—breast cancer	3.96e-05	0.000336	CcSEcCtD
Trimethoprim—Tinnitus—Methotrexate—breast cancer	3.95e-05	0.000335	CcSEcCtD
Trimethoprim—Skin disorder—Capecitabine—breast cancer	3.93e-05	0.000333	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—breast cancer	3.91e-05	0.000332	CcSEcCtD
Trimethoprim—Urticaria—Paclitaxel—breast cancer	3.91e-05	0.000332	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—breast cancer	3.9e-05	0.00033	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—breast cancer	3.9e-05	0.00033	CcSEcCtD
Trimethoprim—Body temperature increased—Paclitaxel—breast cancer	3.89e-05	0.00033	CcSEcCtD
Trimethoprim—Abdominal pain—Paclitaxel—breast cancer	3.89e-05	0.00033	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—breast cancer	3.89e-05	0.000329	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—breast cancer	3.86e-05	0.000328	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—breast cancer	3.85e-05	0.000327	CcSEcCtD
Trimethoprim—Anorexia—Capecitabine—breast cancer	3.85e-05	0.000327	CcSEcCtD
Trimethoprim—Vomiting—Irinotecan—breast cancer	3.84e-05	0.000326	CcSEcCtD
Trimethoprim—Vomiting—Mitoxantrone—breast cancer	3.84e-05	0.000326	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—breast cancer	3.83e-05	0.000324	CcSEcCtD
Trimethoprim—Dizziness—Fluorouracil—breast cancer	3.83e-05	0.000324	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—breast cancer	3.82e-05	0.000324	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—breast cancer	3.81e-05	0.000323	CcSEcCtD
Trimethoprim—Rash—Mitoxantrone—breast cancer	3.81e-05	0.000323	CcSEcCtD
Trimethoprim—Rash—Irinotecan—breast cancer	3.81e-05	0.000323	CcSEcCtD
Trimethoprim—Dermatitis—Mitoxantrone—breast cancer	3.8e-05	0.000323	CcSEcCtD
Trimethoprim—Dermatitis—Irinotecan—breast cancer	3.8e-05	0.000323	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Docetaxel—breast cancer	3.8e-05	0.000322	CcSEcCtD
Trimethoprim—Headache—Mitoxantrone—breast cancer	3.78e-05	0.000321	CcSEcCtD
Trimethoprim—Headache—Irinotecan—breast cancer	3.78e-05	0.000321	CcSEcCtD
Trimethoprim—Insomnia—Docetaxel—breast cancer	3.78e-05	0.00032	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—breast cancer	3.75e-05	0.000318	CcSEcCtD
Trimethoprim—Vomiting—Gemcitabine—breast cancer	3.74e-05	0.000317	CcSEcCtD
Trimethoprim—Dyspnoea—Docetaxel—breast cancer	3.72e-05	0.000316	CcSEcCtD
Trimethoprim—Mental disorder—Methotrexate—breast cancer	3.71e-05	0.000315	CcSEcCtD
Trimethoprim—Rash—Gemcitabine—breast cancer	3.71e-05	0.000314	CcSEcCtD
Trimethoprim—Dermatitis—Gemcitabine—breast cancer	3.71e-05	0.000314	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—breast cancer	3.7e-05	0.000314	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—breast cancer	3.7e-05	0.000313	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—breast cancer	3.69e-05	0.000313	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—breast cancer	3.69e-05	0.000313	CcSEcCtD
Trimethoprim—Headache—Gemcitabine—breast cancer	3.69e-05	0.000312	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Capecitabine—breast cancer	3.68e-05	0.000312	CcSEcCtD
Trimethoprim—Vomiting—Fluorouracil—breast cancer	3.68e-05	0.000312	CcSEcCtD
Trimethoprim—Dyspepsia—Docetaxel—breast cancer	3.68e-05	0.000312	CcSEcCtD
Trimethoprim—Insomnia—Capecitabine—breast cancer	3.66e-05	0.00031	CcSEcCtD
Trimethoprim—Rash—Fluorouracil—breast cancer	3.65e-05	0.000309	CcSEcCtD
Trimethoprim—Dermatitis—Fluorouracil—breast cancer	3.64e-05	0.000309	CcSEcCtD
Trimethoprim—Decreased appetite—Docetaxel—breast cancer	3.63e-05	0.000308	CcSEcCtD
Trimethoprim—Hypersensitivity—Paclitaxel—breast cancer	3.63e-05	0.000308	CcSEcCtD
Trimethoprim—Headache—Fluorouracil—breast cancer	3.62e-05	0.000307	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—breast cancer	3.62e-05	0.000307	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Docetaxel—breast cancer	3.6e-05	0.000306	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—breast cancer	3.6e-05	0.000306	CcSEcCtD
Trimethoprim—Dyspnoea—Capecitabine—breast cancer	3.6e-05	0.000306	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—breast cancer	3.6e-05	0.000305	CcSEcCtD
Trimethoprim—Nausea—Mitoxantrone—breast cancer	3.59e-05	0.000304	CcSEcCtD
Trimethoprim—Nausea—Irinotecan—breast cancer	3.59e-05	0.000304	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—breast cancer	3.58e-05	0.000304	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—breast cancer	3.57e-05	0.000303	CcSEcCtD
Trimethoprim—Constipation—Docetaxel—breast cancer	3.57e-05	0.000303	CcSEcCtD
Trimethoprim—Dyspepsia—Capecitabine—breast cancer	3.56e-05	0.000302	CcSEcCtD
Trimethoprim—Decreased appetite—Capecitabine—breast cancer	3.51e-05	0.000298	CcSEcCtD
Trimethoprim—Nausea—Gemcitabine—breast cancer	3.49e-05	0.000296	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Capecitabine—breast cancer	3.49e-05	0.000296	CcSEcCtD
Trimethoprim—Pruritus—Paclitaxel—breast cancer	3.49e-05	0.000295	CcSEcCtD
Trimethoprim—Mental disorder—Epirubicin—breast cancer	3.47e-05	0.000294	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—breast cancer	3.47e-05	0.000294	CcSEcCtD
Trimethoprim—Constipation—Capecitabine—breast cancer	3.46e-05	0.000293	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—breast cancer	3.45e-05	0.000293	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—breast cancer	3.45e-05	0.000293	CcSEcCtD
Trimethoprim—Feeling abnormal—Docetaxel—breast cancer	3.44e-05	0.000292	CcSEcCtD
Trimethoprim—Nausea—Fluorouracil—breast cancer	3.44e-05	0.000291	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—breast cancer	3.43e-05	0.000291	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—breast cancer	3.42e-05	0.00029	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Docetaxel—breast cancer	3.41e-05	0.000289	CcSEcCtD
Trimethoprim—Diarrhoea—Paclitaxel—breast cancer	3.37e-05	0.000286	CcSEcCtD
Trimethoprim—Feeling abnormal—Capecitabine—breast cancer	3.33e-05	0.000282	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—breast cancer	3.31e-05	0.000281	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—breast cancer	3.31e-05	0.000281	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Capecitabine—breast cancer	3.31e-05	0.00028	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—breast cancer	3.31e-05	0.00028	CcSEcCtD
Trimethoprim—Abdominal pain—Docetaxel—breast cancer	3.3e-05	0.00028	CcSEcCtD
Trimethoprim—Body temperature increased—Docetaxel—breast cancer	3.3e-05	0.00028	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—breast cancer	3.3e-05	0.00028	CcSEcCtD
Trimethoprim—Dizziness—Paclitaxel—breast cancer	3.26e-05	0.000276	CcSEcCtD
Trimethoprim—Cough—Methotrexate—breast cancer	3.22e-05	0.000273	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—breast cancer	3.21e-05	0.000272	CcSEcCtD
Trimethoprim—Urticaria—Capecitabine—breast cancer	3.21e-05	0.000272	CcSEcCtD
Trimethoprim—Abdominal pain—Capecitabine—breast cancer	3.2e-05	0.000271	CcSEcCtD
Trimethoprim—Body temperature increased—Capecitabine—breast cancer	3.2e-05	0.000271	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—breast cancer	3.19e-05	0.000271	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—breast cancer	3.19e-05	0.000271	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—breast cancer	3.19e-05	0.000271	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—breast cancer	3.17e-05	0.000269	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—breast cancer	3.14e-05	0.000266	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—breast cancer	3.14e-05	0.000266	CcSEcCtD
Trimethoprim—Vomiting—Paclitaxel—breast cancer	3.13e-05	0.000265	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.12e-05	0.000264	CcSEcCtD
Trimethoprim—Rash—Paclitaxel—breast cancer	3.11e-05	0.000263	CcSEcCtD
Trimethoprim—Dermatitis—Paclitaxel—breast cancer	3.1e-05	0.000263	CcSEcCtD
Trimethoprim—Vertigo—Epirubicin—breast cancer	3.1e-05	0.000263	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—breast cancer	3.09e-05	0.000262	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—breast cancer	3.09e-05	0.000262	CcSEcCtD
Trimethoprim—Headache—Paclitaxel—breast cancer	3.09e-05	0.000262	CcSEcCtD
Trimethoprim—Hypersensitivity—Docetaxel—breast cancer	3.08e-05	0.000261	CcSEcCtD
Trimethoprim—Confusional state—Methotrexate—breast cancer	3.03e-05	0.000257	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—breast cancer	3.03e-05	0.000257	CcSEcCtD
Trimethoprim—Cough—Epirubicin—breast cancer	3.01e-05	0.000255	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—breast cancer	3.01e-05	0.000255	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—breast cancer	2.99e-05	0.000253	CcSEcCtD
Trimethoprim—Hypersensitivity—Capecitabine—breast cancer	2.98e-05	0.000252	CcSEcCtD
Trimethoprim—Pruritus—Docetaxel—breast cancer	2.95e-05	0.00025	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—breast cancer	2.95e-05	0.00025	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—breast cancer	2.95e-05	0.00025	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—breast cancer	2.94e-05	0.000249	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—breast cancer	2.94e-05	0.000249	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—breast cancer	2.93e-05	0.000249	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—breast cancer	2.93e-05	0.000248	CcSEcCtD
Trimethoprim—Nausea—Paclitaxel—breast cancer	2.93e-05	0.000248	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—breast cancer	2.92e-05	0.000248	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.92e-05	0.000247	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—breast cancer	2.87e-05	0.000243	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—breast cancer	2.87e-05	0.000243	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—breast cancer	2.86e-05	0.000243	CcSEcCtD
Trimethoprim—Pruritus—Capecitabine—breast cancer	2.86e-05	0.000242	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—breast cancer	2.86e-05	0.000242	CcSEcCtD
Trimethoprim—Diarrhoea—Docetaxel—breast cancer	2.86e-05	0.000242	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—breast cancer	2.84e-05	0.000241	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—breast cancer	2.82e-05	0.000239	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—breast cancer	2.81e-05	0.000238	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—breast cancer	2.79e-05	0.000236	CcSEcCtD
Trimethoprim—Shock—Epirubicin—breast cancer	2.77e-05	0.000235	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—breast cancer	2.77e-05	0.000235	CcSEcCtD
Trimethoprim—Diarrhoea—Capecitabine—breast cancer	2.77e-05	0.000234	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—breast cancer	2.76e-05	0.000234	CcSEcCtD
Trimethoprim—Dizziness—Docetaxel—breast cancer	2.76e-05	0.000234	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—breast cancer	2.76e-05	0.000234	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—breast cancer	2.74e-05	0.000232	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—breast cancer	2.74e-05	0.000232	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—breast cancer	2.72e-05	0.000231	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—breast cancer	2.72e-05	0.00023	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—breast cancer	2.72e-05	0.00023	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—breast cancer	2.71e-05	0.00023	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.7e-05	0.000229	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—breast cancer	2.68e-05	0.000228	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—breast cancer	2.68e-05	0.000227	CcSEcCtD
Trimethoprim—Dizziness—Capecitabine—breast cancer	2.67e-05	0.000227	CcSEcCtD
Trimethoprim—Vomiting—Docetaxel—breast cancer	2.65e-05	0.000225	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—breast cancer	2.65e-05	0.000225	CcSEcCtD
Trimethoprim—Rash—Docetaxel—breast cancer	2.63e-05	0.000223	CcSEcCtD
Trimethoprim—Dermatitis—Docetaxel—breast cancer	2.63e-05	0.000223	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—breast cancer	2.63e-05	0.000223	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—breast cancer	2.62e-05	0.000222	CcSEcCtD
Trimethoprim—Headache—Docetaxel—breast cancer	2.62e-05	0.000222	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—breast cancer	2.61e-05	0.000221	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—breast cancer	2.6e-05	0.00022	CcSEcCtD
Trimethoprim—Vomiting—Capecitabine—breast cancer	2.57e-05	0.000218	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—breast cancer	2.57e-05	0.000218	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—breast cancer	2.56e-05	0.000217	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—breast cancer	2.56e-05	0.000217	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—breast cancer	2.55e-05	0.000216	CcSEcCtD
Trimethoprim—Rash—Capecitabine—breast cancer	2.55e-05	0.000216	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—breast cancer	2.55e-05	0.000216	CcSEcCtD
Trimethoprim—Dermatitis—Capecitabine—breast cancer	2.55e-05	0.000216	CcSEcCtD
Trimethoprim—Headache—Capecitabine—breast cancer	2.53e-05	0.000215	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—breast cancer	2.53e-05	0.000215	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—breast cancer	2.51e-05	0.000213	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—breast cancer	2.48e-05	0.000211	CcSEcCtD
Trimethoprim—Nausea—Docetaxel—breast cancer	2.48e-05	0.00021	CcSEcCtD
Trimethoprim—Feeling abnormal—Methotrexate—breast cancer	2.48e-05	0.00021	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—breast cancer	2.48e-05	0.00021	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—breast cancer	2.46e-05	0.000209	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—breast cancer	2.45e-05	0.000208	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—breast cancer	2.43e-05	0.000206	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—breast cancer	2.41e-05	0.000204	CcSEcCtD
Trimethoprim—Nausea—Capecitabine—breast cancer	2.4e-05	0.000204	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—breast cancer	2.39e-05	0.000203	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—breast cancer	2.38e-05	0.000202	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—breast cancer	2.38e-05	0.000202	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.37e-05	0.000201	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—breast cancer	2.36e-05	0.0002	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—breast cancer	2.32e-05	0.000197	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—breast cancer	2.32e-05	0.000197	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—breast cancer	2.3e-05	0.000195	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—breast cancer	2.29e-05	0.000194	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—breast cancer	2.27e-05	0.000192	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—breast cancer	2.25e-05	0.000191	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—breast cancer	2.24e-05	0.00019	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—breast cancer	2.23e-05	0.000189	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—breast cancer	2.23e-05	0.000189	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—breast cancer	2.23e-05	0.000189	CcSEcCtD
Trimethoprim—Hypersensitivity—Methotrexate—breast cancer	2.22e-05	0.000188	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—breast cancer	2.15e-05	0.000182	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—breast cancer	2.13e-05	0.000181	CcSEcCtD
Trimethoprim—Pruritus—Methotrexate—breast cancer	2.13e-05	0.00018	CcSEcCtD
Trimethoprim—Hypersensitivity—Epirubicin—breast cancer	2.07e-05	0.000176	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—breast cancer	2.07e-05	0.000175	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—breast cancer	2.06e-05	0.000175	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—breast cancer	2.06e-05	0.000175	CcSEcCtD
Trimethoprim—Diarrhoea—Methotrexate—breast cancer	2.06e-05	0.000175	CcSEcCtD
Trimethoprim—Pruritus—Epirubicin—breast cancer	1.99e-05	0.000169	CcSEcCtD
Trimethoprim—Dizziness—Methotrexate—breast cancer	1.99e-05	0.000169	CcSEcCtD
Trimethoprim—Diarrhoea—Epirubicin—breast cancer	1.93e-05	0.000163	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—breast cancer	1.92e-05	0.000163	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—breast cancer	1.91e-05	0.000162	CcSEcCtD
Trimethoprim—Rash—Methotrexate—breast cancer	1.9e-05	0.000161	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—breast cancer	1.9e-05	0.000161	CcSEcCtD
Trimethoprim—Headache—Methotrexate—breast cancer	1.89e-05	0.00016	CcSEcCtD
Trimethoprim—Dizziness—Epirubicin—breast cancer	1.86e-05	0.000158	CcSEcCtD
Trimethoprim—Pruritus—Doxorubicin—breast cancer	1.84e-05	0.000156	CcSEcCtD
Trimethoprim—Vomiting—Epirubicin—breast cancer	1.79e-05	0.000152	CcSEcCtD
Trimethoprim—Nausea—Methotrexate—breast cancer	1.79e-05	0.000152	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—breast cancer	1.78e-05	0.000151	CcSEcCtD
Trimethoprim—Rash—Epirubicin—breast cancer	1.78e-05	0.000151	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—breast cancer	1.77e-05	0.00015	CcSEcCtD
Trimethoprim—Headache—Epirubicin—breast cancer	1.76e-05	0.00015	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—breast cancer	1.72e-05	0.000146	CcSEcCtD
Trimethoprim—Nausea—Epirubicin—breast cancer	1.67e-05	0.000142	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—breast cancer	1.66e-05	0.00014	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—breast cancer	1.64e-05	0.000139	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—breast cancer	1.64e-05	0.000139	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—breast cancer	1.63e-05	0.000138	CcSEcCtD
Trimethoprim—Nausea—Doxorubicin—breast cancer	1.55e-05	0.000131	CcSEcCtD
Trimethoprim—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.5e-06	5.84e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ESRRA—breast cancer	4.5e-06	5.84e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—breast cancer	4.48e-06	5.81e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—breast cancer	4.47e-06	5.8e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.46e-06	5.78e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—breast cancer	4.46e-06	5.78e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ACHE—breast cancer	4.46e-06	5.78e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MED12—breast cancer	4.39e-06	5.69e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—DPYD—breast cancer	4.39e-06	5.69e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—breast cancer	4.39e-06	5.68e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALDOA—breast cancer	4.32e-06	5.6e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HADHB—breast cancer	4.27e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPI—breast cancer	4.27e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.23e-06	5.48e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP17A1—breast cancer	4.22e-06	5.47e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA3—breast cancer	4.2e-06	5.44e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ENO1—breast cancer	4.18e-06	5.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS1—breast cancer	4.18e-06	5.41e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC2A2—breast cancer	4.17e-06	5.4e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.16e-06	5.39e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—breast cancer	4.14e-06	5.37e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.11e-06	5.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—DPYD—breast cancer	4.1e-06	5.32e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MED12—breast cancer	4.1e-06	5.32e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2D6—breast cancer	4.1e-06	5.31e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CPT1A—breast cancer	4.08e-06	5.29e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTR—breast cancer	4.08e-06	5.29e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCG2—breast cancer	4.08e-06	5.29e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.07e-06	5.28e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.07e-06	5.28e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALDOA—breast cancer	4.04e-06	5.23e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOA2—breast cancer	4.02e-06	5.21e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HPGDS—breast cancer	4e-06	5.19e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HBA1—breast cancer	3.98e-06	5.16e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—breast cancer	3.94e-06	5.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA3—breast cancer	3.92e-06	5.08e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ADSL—breast cancer	3.9e-06	5.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FHL2—breast cancer	3.9e-06	5.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NME1—breast cancer	3.9e-06	5.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—UMPS—breast cancer	3.9e-06	5.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PHGDH—breast cancer	3.9e-06	5.06e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FASN—breast cancer	3.9e-06	5.05e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC2A2—breast cancer	3.89e-06	5.05e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ACHE—breast cancer	3.88e-06	5.03e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—breast cancer	3.88e-06	5.03e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BCHE—breast cancer	3.88e-06	5.03e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.85e-06	4.99e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A5—breast cancer	3.84e-06	4.97e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LDHB—breast cancer	3.83e-06	4.96e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HPSE—breast cancer	3.83e-06	4.96e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BRIP1—breast cancer	3.83e-06	4.96e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CPT1A—breast cancer	3.82e-06	4.94e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTR—breast cancer	3.82e-06	4.94e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCG2—breast cancer	3.82e-06	4.94e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—breast cancer	3.81e-06	4.93e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.77e-06	4.89e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HPGDS—breast cancer	3.74e-06	4.85e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HBA1—breast cancer	3.72e-06	4.82e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NQO1—breast cancer	3.71e-06	4.8e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC2A1—breast cancer	3.71e-06	4.8e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP17A1—breast cancer	3.68e-06	4.76e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS1—breast cancer	3.64e-06	4.72e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ENO1—breast cancer	3.64e-06	4.72e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA3—breast cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HMMR—breast cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCC1—breast cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ACHE—breast cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—breast cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP3A4—breast cancer	3.61e-06	4.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.6e-06	4.66e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2D6—breast cancer	3.57e-06	4.63e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1B1—breast cancer	3.55e-06	4.6e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—breast cancer	3.52e-06	4.56e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.52e-06	4.56e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA2—breast cancer	3.5e-06	4.54e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HSP90AA1—breast cancer	3.48e-06	4.51e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP17A1—breast cancer	3.44e-06	4.45e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.4e-06	4.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS1—breast cancer	3.4e-06	4.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ENO1—breast cancer	3.4e-06	4.41e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FASN—breast cancer	3.4e-06	4.4e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOA1—breast cancer	3.39e-06	4.39e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.39e-06	4.39e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BCHE—breast cancer	3.38e-06	4.39e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—breast cancer	3.37e-06	4.37e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A5—breast cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—STK11—breast cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP19A1—breast cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2D6—breast cancer	3.33e-06	4.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA9—breast cancer	3.32e-06	4.3e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA4—breast cancer	3.32e-06	4.3e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA2—breast cancer	3.27e-06	4.24e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPX2—breast cancer	3.24e-06	4.19e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA2—breast cancer	3.24e-06	4.19e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NQO1—breast cancer	3.23e-06	4.18e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC2A1—breast cancer	3.23e-06	4.18e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SULT1A1—breast cancer	3.2e-06	4.14e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPX4—breast cancer	3.2e-06	4.14e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—breast cancer	3.19e-06	4.13e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FASN—breast cancer	3.17e-06	4.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BCHE—breast cancer	3.16e-06	4.1e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP3A4—breast cancer	3.15e-06	4.08e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.14e-06	4.06e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A5—breast cancer	3.12e-06	4.05e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH1—breast cancer	3.12e-06	4.04e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA1—breast cancer	3.12e-06	4.04e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—breast cancer	3.11e-06	4.03e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—COMT—breast cancer	3.11e-06	4.02e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1B1—breast cancer	3.1e-06	4.01e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTP1—breast cancer	3.09e-06	4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NAT2—breast cancer	3.09e-06	4e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.08e-06	3.99e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HMOX1—breast cancer	3.05e-06	3.95e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ITPR1—breast cancer	3.04e-06	3.94e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HSP90AA1—breast cancer	3.04e-06	3.93e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NQO1—breast cancer	3.02e-06	3.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC2A1—breast cancer	3.02e-06	3.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.95e-06	3.83e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA1—breast cancer	2.95e-06	3.83e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP3A4—breast cancer	2.94e-06	3.81e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.93e-06	3.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—breast cancer	2.93e-06	3.79e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—STK11—breast cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP19A1—breast cancer	2.91e-06	3.77e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1B1—breast cancer	2.89e-06	3.75e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMS—breast cancer	2.87e-06	3.72e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.84e-06	3.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTM1—breast cancer	2.84e-06	3.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOR1—breast cancer	2.84e-06	3.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.84e-06	3.67e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—breast cancer	2.78e-06	3.6e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA1—breast cancer	2.76e-06	3.57e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPX1—breast cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—STK11—breast cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP19A1—breast cancer	2.72e-06	3.52e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MED12—breast cancer	2.71e-06	3.51e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—DPYD—breast cancer	2.71e-06	3.51e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—COMT—breast cancer	2.71e-06	3.51e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTP1—breast cancer	2.69e-06	3.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1A1—breast cancer	2.69e-06	3.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ERCC2—breast cancer	2.67e-06	3.46e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALDOA—breast cancer	2.66e-06	3.45e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HMOX1—breast cancer	2.66e-06	3.44e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ITPR1—breast cancer	2.65e-06	3.43e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—breast cancer	2.6e-06	3.37e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA3—breast cancer	2.59e-06	3.35e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC2A2—breast cancer	2.57e-06	3.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.55e-06	3.31e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—COMT—breast cancer	2.53e-06	3.27e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCG2—breast cancer	2.52e-06	3.26e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CPT1A—breast cancer	2.52e-06	3.26e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTR—breast cancer	2.52e-06	3.26e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTP1—breast cancer	2.52e-06	3.26e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—breast cancer	2.51e-06	3.25e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMS—breast cancer	2.5e-06	3.24e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HMOX1—breast cancer	2.48e-06	3.21e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ITPR1—breast cancer	2.48e-06	3.21e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLA2G4A—breast cancer	2.47e-06	3.21e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOR1—breast cancer	2.47e-06	3.21e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTM1—breast cancer	2.47e-06	3.21e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HPGDS—breast cancer	2.47e-06	3.2e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HBA1—breast cancer	2.45e-06	3.18e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—breast cancer	2.39e-06	3.1e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACHE—breast cancer	2.39e-06	3.1e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—breast cancer	2.38e-06	3.09e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPX1—breast cancer	2.37e-06	3.07e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1A1—breast cancer	2.35e-06	3.04e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMS—breast cancer	2.34e-06	3.03e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ERCC2—breast cancer	2.33e-06	3.01e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAV1—breast cancer	2.32e-06	3e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.31e-06	3e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTM1—breast cancer	2.31e-06	3e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOR1—breast cancer	2.31e-06	3e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—breast cancer	2.27e-06	2.94e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP17A1—breast cancer	2.27e-06	2.94e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS1—breast cancer	2.24e-06	2.91e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ENO1—breast cancer	2.24e-06	2.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPX1—breast cancer	2.21e-06	2.87e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.21e-06	2.87e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2D6—breast cancer	2.2e-06	2.85e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1A1—breast cancer	2.19e-06	2.84e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—breast cancer	2.19e-06	2.83e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ERCC2—breast cancer	2.17e-06	2.82e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA2—breast cancer	2.16e-06	2.8e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—breast cancer	2.11e-06	2.73e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FASN—breast cancer	2.09e-06	2.71e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BCHE—breast cancer	2.08e-06	2.7e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A5—breast cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—breast cancer	2.04e-06	2.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAV1—breast cancer	2.02e-06	2.61e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NQO1—breast cancer	1.99e-06	2.58e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC2A1—breast cancer	1.99e-06	2.58e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1B1—breast cancer	1.91e-06	2.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAV1—breast cancer	1.88e-06	2.44e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.87e-06	2.42e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—breast cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—breast cancer	1.84e-06	2.38e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALB—breast cancer	1.83e-06	2.37e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA1—breast cancer	1.82e-06	2.36e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.8e-06	2.33e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—STK11—breast cancer	1.79e-06	2.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP19A1—breast cancer	1.79e-06	2.32e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NOS3—breast cancer	1.75e-06	2.27e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—breast cancer	1.72e-06	2.22e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—COMT—breast cancer	1.67e-06	2.16e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTP1—breast cancer	1.66e-06	2.15e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HMOX1—breast cancer	1.64e-06	2.12e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ITPR1—breast cancer	1.63e-06	2.12e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—breast cancer	1.62e-06	2.09e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—breast cancer	1.62e-06	2.09e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—breast cancer	1.6e-06	2.07e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALB—breast cancer	1.59e-06	2.07e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—breast cancer	1.57e-06	2.03e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMS—breast cancer	1.54e-06	2e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NOS3—breast cancer	1.53e-06	1.98e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOR1—breast cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTM1—breast cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—breast cancer	1.51e-06	1.96e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALB—breast cancer	1.49e-06	1.93e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPX1—breast cancer	1.46e-06	1.89e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1A1—breast cancer	1.45e-06	1.87e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ERCC2—breast cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NOS3—breast cancer	1.42e-06	1.85e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—breast cancer	1.41e-06	1.82e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—breast cancer	1.4e-06	1.81e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—breast cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—breast cancer	1.35e-06	1.75e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—breast cancer	1.32e-06	1.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—breast cancer	1.3e-06	1.69e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAV1—breast cancer	1.24e-06	1.61e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—breast cancer	1.22e-06	1.58e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—breast cancer	1.14e-06	1.47e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—breast cancer	1.13e-06	1.47e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—breast cancer	9.95e-07	1.29e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—breast cancer	9.85e-07	1.28e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALB—breast cancer	9.82e-07	1.27e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NOS3—breast cancer	9.4e-07	1.22e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—breast cancer	8.67e-07	1.12e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—breast cancer	8.59e-07	1.11e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—breast cancer	8.58e-07	1.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—breast cancer	8.05e-07	1.04e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—breast cancer	8.02e-07	1.04e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—breast cancer	7.49e-07	9.71e-06	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—breast cancer	7.01e-07	9.08e-06	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—breast cancer	6.55e-07	8.49e-06	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—breast cancer	5.29e-07	6.85e-06	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—breast cancer	4.32e-07	5.6e-06	CbGpPWpGaD
